Objective To assess direct oral anticoagulant (DOAC) adherence and to determine possible determinants for suboptimal adherence in Dutch patients with atrial fibrillation (AF). Methods Cross-sectional study of DOAC users who completed a self-reported questionnaire. Adherence was measured with Morisky8-item Medication Adherence Scale (MMAS-8). Logistic regression analysis was conducted to investigate determinants affecting adherence. Results 398 DOAC users completed the questionnaire (mean age 70.6 9.2years). Approximately one in four patients had suboptimal adherence (MMAS-8 < 8). Multivariable analysis showed that patients who felt to have received conflicting information about the treatment, patients with higher educational level and ...
Aims This study aimed to: (a) determine adherence rates to oral anticoagulants in atrial fibrillatio...
Data regarding adherence and minor bleeding on direct oral anticoagulants in everyday life are still...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...
© 2016, Springer International Publishing Switzerland. The role of the direct oral anticoagulants (D...
Background: The aim of this study was to investigate the proportion of patients who have suboptimal ...
Aim. To assess adherence to new oral anticoagulants (NOAC) or warfarin therapy and to study the fact...
Objective: The overall aim of this dissertation was to provide a better understanding of adherence ...
Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated with...
© 2018, The Author(s) 2018. Background: The aim of this study was to investigate the proportion of p...
[[abstract]]Objective: To investigate anticoagulant adherence and its associated factors, including ...
Background Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable e...
[[abstract]]Objective To investigate anticoagulant adherence and its associated factors, including d...
International audienceDirect oral anticoagulants (DOACs) are used for treatment of venous thromboemb...
Abstract Background Differences in adherence may represent drug properties (e.g. dosing interval) or...
BackgroundSince non-vitamin K antagonist oral anticoagulants (NOACs) do not require coagulation moni...
Aims This study aimed to: (a) determine adherence rates to oral anticoagulants in atrial fibrillatio...
Data regarding adherence and minor bleeding on direct oral anticoagulants in everyday life are still...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...
© 2016, Springer International Publishing Switzerland. The role of the direct oral anticoagulants (D...
Background: The aim of this study was to investigate the proportion of patients who have suboptimal ...
Aim. To assess adherence to new oral anticoagulants (NOAC) or warfarin therapy and to study the fact...
Objective: The overall aim of this dissertation was to provide a better understanding of adherence ...
Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated with...
© 2018, The Author(s) 2018. Background: The aim of this study was to investigate the proportion of p...
[[abstract]]Objective: To investigate anticoagulant adherence and its associated factors, including ...
Background Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable e...
[[abstract]]Objective To investigate anticoagulant adherence and its associated factors, including d...
International audienceDirect oral anticoagulants (DOACs) are used for treatment of venous thromboemb...
Abstract Background Differences in adherence may represent drug properties (e.g. dosing interval) or...
BackgroundSince non-vitamin K antagonist oral anticoagulants (NOACs) do not require coagulation moni...
Aims This study aimed to: (a) determine adherence rates to oral anticoagulants in atrial fibrillatio...
Data regarding adherence and minor bleeding on direct oral anticoagulants in everyday life are still...
Background:Patients' knowledge regarding their oral anticoagulant (OAC) treatment for stroke prevent...